Synthroid 0.137 MG Oral Tablet

RxCUI
966271
RxNorm name
Synthroid 0.137 MG Oral Tablet
Display name
Synthroid 0.137 MG Oral Tablet
Full name
Synthroid 0.137 MG Oral Tablet
Term type
SY
Status
DailyMed mapping
Updated
2026-06-04 23:38:49

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
SynthroidLEVOTHYROXINE SODIUMAbbVie Inc.1e11ad30-1041-4520-10b0-8f9d30d30fcc2024-02-20Boxed warning, Warnings, Adverse reactionsExact identifier
rxcui: 966271

DailyMed RxNorm Mappings#

Set ID, RxNorm string, TTY table
Set IDRxNorm stringTTYSPL versionLabelEffective
1e11ad30-1041-4520-10b0-8f9d30d30fccSynthroid 0.137 MG Oral TabletSY1537These highlights do not include all the information needed to use SYNTHROID safely and effectively. See full prescribing information for SYNTHROID. SYNTHROID® (levothyroxine sodium) tablets, for oral use Initial U.S. Approval: 200220240220
1e11ad30-1041-4520-10b0-8f9d30d30fccSynthroid 137 MCG Oral TabletSY1537These highlights do not include all the information needed to use SYNTHROID safely and effectively. See full prescribing information for SYNTHROID. SYNTHROID® (levothyroxine sodium) tablets, for oral use Initial U.S. Approval: 200220240220
1e11ad30-1041-4520-10b0-8f9d30d30fccSYNTHROID 137 MCG Oral TabletPSN1537These highlights do not include all the information needed to use SYNTHROID safely and effectively. See full prescribing information for SYNTHROID. SYNTHROID® (levothyroxine sodium) tablets, for oral use Initial U.S. Approval: 200220240220
1e11ad30-1041-4520-10b0-8f9d30d30fcclevothyroxine sodium 0.137 MG Oral Tablet [Synthroid]SBD1537These highlights do not include all the information needed to use SYNTHROID safely and effectively. See full prescribing information for SYNTHROID. SYNTHROID® (levothyroxine sodium) tablets, for oral use Initial U.S. Approval: 200220240220
abe005b2-d962-4ba7-9cb6-a09d35e68ae7SYNTHROID 137 MCG Oral TabletPSN5SYNTHROID® (levothyroxine sodium tablets, USP)20140505
abe005b2-d962-4ba7-9cb6-a09d35e68ae7Synthroid 137 MCG Oral TabletSY5SYNTHROID® (levothyroxine sodium tablets, USP)20140505
abe005b2-d962-4ba7-9cb6-a09d35e68ae7levothyroxine sodium 0.137 MG Oral Tablet [Synthroid]SBD5SYNTHROID® (levothyroxine sodium tablets, USP)20140505
abe005b2-d962-4ba7-9cb6-a09d35e68ae7Synthroid 0.137 MG Oral TabletSY5SYNTHROID® (levothyroxine sodium tablets, USP)20140505
b9aea421-ae9b-439a-90a3-07a0a50e835dSynthroid 0.137 MG Oral TabletSY2These highlights do not include all the information needed to use SYNTHROID® safely and effectively. See full prescribing information for SYNTHROID. SYNTHROID® (levothyroxine sodium) tablets, for oral use Initial U.S. Approval: 200220171116
b9aea421-ae9b-439a-90a3-07a0a50e835dlevothyroxine sodium 0.137 MG Oral Tablet [Synthroid]SBD2These highlights do not include all the information needed to use SYNTHROID® safely and effectively. See full prescribing information for SYNTHROID. SYNTHROID® (levothyroxine sodium) tablets, for oral use Initial U.S. Approval: 200220171116
b9aea421-ae9b-439a-90a3-07a0a50e835dSYNTHROID 137 MCG Oral TabletPSN2These highlights do not include all the information needed to use SYNTHROID® safely and effectively. See full prescribing information for SYNTHROID. SYNTHROID® (levothyroxine sodium) tablets, for oral use Initial U.S. Approval: 200220171116
b9aea421-ae9b-439a-90a3-07a0a50e835dSynthroid 137 MCG Oral TabletSY2These highlights do not include all the information needed to use SYNTHROID® safely and effectively. See full prescribing information for SYNTHROID. SYNTHROID® (levothyroxine sodium) tablets, for oral use Initial U.S. Approval: 200220171116